ISC

Chinese trial supports stronger antiplatelet for patients ineligible for lytics, thrombectomy

Among six interventions, uric acid exceeded efficacy boundaries

Pair of phase III trials lay the groundwork for expanding indication

Trial did not show definite harm, but benefit is unlikely

Racial disparities narrowed as a result of hospital and community intervention

Stroke neurologists debate skipping secondary prevention anticoagulants for some

Middle-age patients with worse sleep saw increased white matter hyperintensities on MRI

Data from China strengthen the evidence base for off-label use

Combined isosorbide mononitrate and cilostazol feasible, well tolerated in these patients

Registry suggests undertreatment, particularly of women and healthier individuals

Infusion before mechanical thrombectomy reduced important outcomes in small phase I/II trial

Large study detects interaction between genetic susceptibility and neighborhood deprivation

STROKE AF studied a group not typically considered for Afib detection and management

Lower-level hospitals performing a "surprising" number of thrombectomies